These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9308230)

  • 1. Murine and human 3'IgH regulatory sequences.
    Birshtein BK; Chen C; Saleque S; Michaelson JS; Singh M; Little RD
    Curr Top Microbiol Immunol; 1997; 224():73-80. PubMed ID: 9308230
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L; Groudine M
    Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin gene associated chromosomal translocations in B-cell derived tumors.
    Klein G
    Curr Top Microbiol Immunol; 1999; 246():161-7. PubMed ID: 10396052
    [No Abstract]   [Full Text] [Related]  

  • 4. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.
    Taub R; Kirsch I; Morton C; Lenoir G; Swan D; Tronick S; Aaronson S; Leder P
    Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7837-41. PubMed ID: 6818551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors.
    Klein G
    Genes Chromosomes Cancer; 1989 Sep; 1(1):3-8. PubMed ID: 2487145
    [No Abstract]   [Full Text] [Related]  

  • 6. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
    Yan Y; Park SS; Janz S; Eckhardt LA
    Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
    Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
    Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc oncogene activation in B and T lymphoid tumours.
    Adams JM; Cory S
    Proc R Soc Lond B Biol Sci; 1985 Oct; 226(1242):59-72. PubMed ID: 2866524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies.
    Fiancette R; Amin R; Truffinet V; Vincent-Fabert C; Cogné N; Cogné M; Denizot Y
    Leuk Res; 2010 Aug; 34(8):1043-51. PubMed ID: 20018375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illegitimate recombinations between c-myc and immunoglobulin loci are remodeled by deletions in mouse plasmacytomas but not in Burkitt's lymphomas.
    Müller JR; Janz S; Potter M
    Curr Top Microbiol Immunol; 1995; 194():425-9. PubMed ID: 7895518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.
    Klein G
    Cell; 1983 Feb; 32(2):311-5. PubMed ID: 6402307
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromatin structural changes in the putative regulatory region of c-myc accompany the translocation in a Burkitt lymphoma.
    Siebenlist U; Hennighausen L; Battey J; Leder P
    Curr Top Microbiol Immunol; 1984; 113():183-9. PubMed ID: 6434235
    [No Abstract]   [Full Text] [Related]  

  • 14. The t(8;14) chromosome translocation of the Burkitt lymphoma cell line Daudi occurred during immunoglobulin gene rearrangement and involved the heavy chain diversity region.
    Haluska FG; Tsujimoto Y; Croce CM
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6835-9. PubMed ID: 3116544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma.
    Corcoran LM; Cory S; Adams JM
    Cell; 1985 Jan; 40(1):71-9. PubMed ID: 2981633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forward and reverse changes in Ig/myc translocation carrying tumors.
    Klein G
    Princess Takamatsu Symp; 1989; 20():135-42. PubMed ID: 2562178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant downregulation of IgH 3' enhancer activity and c-myc expression in a plasmacytoma x fibroblast environment: implications for dysregulation of translocated c-myc.
    Thøger Andersen AS; Jensen AW; Grant P; Arulampalam V; Pettersson S; Junker S
    Mol Immunol; 1997 Feb; 34(2):97-107. PubMed ID: 9188842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma.
    Rabbitts TH; Forster A; Baer R; Hamlyn PH
    Nature; 1983 Dec 22-1984 Jan 4; 306(5945):806-9. PubMed ID: 6419124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombination of the c-myc gene with IgH enhancer-S mu sequences in a murine plasmacytoma (DCPC21) without visible chromosomal translocations.
    Ohno S; Migita S; Murakami S
    Curr Top Microbiol Immunol; 1990; 166():267-78. PubMed ID: 2127395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.